Mereo BioPharma Group Plc (MREO)
0.342
-0.02
(-5.18%)
USD |
NASDAQ |
Mar 20, 16:00
0.3353
-0.01
(-1.96%)
After-Hours: 20:00
Mereo BioPharma Group Research and Development Expense (Quarterly) : 4.187M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 2.309M |
| Autolus Therapeutics Plc | 27.72M |
| Bicycle Therapeutics Plc | 58.15M |
| AstraZeneca PLC | 3.725B |